Why Huntington Bancshares Shares Surged Around 10%; Here Are 72 Biggest Movers From Friday

Author: Lisa Levin | October 24, 2022 05:37am

Gainers

• Huadi International Group Co., Ltd. (NASDAQ:HUDI) jumped 89.3% to close at $58.92 on Friday.
• Altamira Therapeutics Ltd. (NASDAQ:CYTO) climbed 58.6% to close at $0.5197 on Friday after the company announced divestiture of its inner ear development assets.
• Missfresh Limited (NASDAQ:MF) gained 57.5% to close at $2.52.
• Enservco Corporation (NYSE:ENSV) climbed 37.4% to close at $2.02.
• Kaleyra, Inc. (NYSE:KLR) gained 24.9% to close at $0.8616.
• Veris Residential, Inc. (NYSE:VRE) surged 23.3% to close at $15.31 after Kushner Companies made an offer to acquire the company for $16 per share.
• Matinas BioPharma Holdings, Inc. (NYSE:MTNB) rose 22.2% to settle at $0.8538. Matinas BioPharma announced interim data from the Phase 2 EnACT trial of MAT2203 for the treatment of cryptococcal meningitis, exceeding primary endpoint threshold.
• Candel Therapeutics, Inc. (NASDAQ:CADL) gained 21.6% to close at $1.80.
• Energy Focus, Inc (NASDAQ:EFOI) shares climbed 21.5% to close at $0.4900. Energy Focus, last month, named Lesley Matt as CEO.
• Leju Holdings Limited (NYSE:LEJU) gained 21.1% to settle at $1.61.
• Rail Vision Ltd. (NASDAQ:RVSN) gained 20.5% to close at $0.5898.
• Rockley Photonics Holdings Limited (NYSE:RKLY) surged 20.1% to settle at $0.6262.
• The Boston Beer Company, Inc. (NYSE:SAM) jumped 19.7% to close at $402.28 after the company reported better-than-expected Q3 adjusted EPS and sales results.
• MacroGenics, Inc. (NASDAQ:MGNX) rose 19.4% to close at $4.80.
• TuanChe Limited (NASDAQ:TC) climbed 19.1% to settle at $7.87.
• Zentek Ltd. (NASDAQ:ZTEK) gained 18.9% to close at $1.57.
• Yunji Inc. (NASDAQ:YJ) rose 18.6% to close at $1.02.
• Snow Lake Resources Ltd. (NASDAQ:LITM) climbed 18.5% to close at $2.43.
• Biohaven Ltd. (NYSE:BHVN) gained 17.7% to close at $14.08. Biohaven reported pricing of public offering of 25 million common shares at a price of $10.50 per share.
• Amprius Technologies, Inc. (NASDAQ:AMPX) climbed 17.6% to close at $11.11. Amprius Technologies was awarded a $50 million cost-sharing grant from the U.S. Department of Energy's Office of Manufacturing and Energy Supply Chains.
• Healthcare Triangle, Inc. (NASDAQ:HCTI) gained 17.2% to close at $0.3875.
• AppTech Payments Corp. (NASDAQ:APCX) gained 16.4% to settle at $0.8849.
• Pacific Biosciences of California, Inc. (NASDAQ:PACB) climbed 16.3% to close at $7.77.
• Biotricity, Inc. (NASDAQ:BTCY) rose 15.7% to close at $1.10.
• uCloudlink Group Inc. (NASDAQ:UCL) rose 15.5% to close at $0.69.
• Intelligent Living Application Group Inc. (NASDAQ:ILAG) rose 14.9% to close at $2.70.
• Microvast Holdings, Inc. (NASDAQ:MVST) surged 13.1% to close at $2.50.
• Novavax, Inc. (NASDAQ:NVAX) gained 12.6% to close at $19.34 in sympathy with Pfizer, which is reportedly thinking about increasing the price for COVID-19 boosters.
• Atara Biotherapeutics, Inc. (NASDAQ:ATRA) jumped 12.5% to close at $4.23
• Piedmont Lithium Inc. (NASDAQ:PLL) rose 12.1% to close at $60.02.
• 1st Source Corporation (NASDAQ:SRCE) gained 12.1% to close at $55.89.
• BioNTech SE (NASDAQ:BNTX) climbed 11.2% to close at $131.64 following reports suggesting vaccine makers could possibly raise the prices of COVID-19 shots.
• Schlumberger Limited (NYSE:SLB) gained 10.3% to close at $50.41 following upbeat quarterly earnings.
• Calliditas Therapeutics AB (NASDAQ:CALT) gained 10.3% to settle at $12.68 after dipping 15% on Thursday.
• Super League Gaming, Inc. (NASDAQ:SLGG) gained 10.2% to close at $0.6835.
• Huntington Bancshares Incorporated (NASDAQ:HBAN) gained 9.5% to close at $14.45 after the company reported better-than-expected Q3 EPS results.
• Pennsylvania Real Estate Investment Trust (NYSE:PEI) rose 9.4% to close at $2.90.
• Hawaiian Holdings, Inc. (NASDAQ:HA) shares gained 8.9% to close at $15.33. Hawaiian Airlines announced an agreement with Amazon to operate freighter aircraft.
• Moderna, Inc. (NASDAQ:MRNA) surged 8.4% to close at $128.32 after SVB Leerink upgraded the stock from Underperform to Market Perform and raised the price target from $74 to $101.
• Statera Biopharma, Inc. (NASDAQ:STAB) gained 8.2% to close at $0.1658. Statera Biopharma recently signed a binding Memorandum of Understanding with Holobeam Technologies Inc.
• FedNat Holding Company (NASDAQ:FNHC) gained 6.6% to close at $0.5960 after dipping over 8% on Thursday.

 

Losers

• Immunic, Inc. (NASDAQ:IMUX) shares tumbled 77.4% to close at $2.08 on Friday after the company reported the pre-planned Phase 1b interim analysis of IMU-935 in psoriasis patients was confounded by a high placebo rate. Two active arms did not separate from the placebo.
• NextPlay Technologies, Inc. (NASDAQ:NXTP) declined 33.2% to close at $0.2763. NextPlay Technologies recently announced its NextFintech division received commitment for a $15 million strategic investment.
• Kalera Public Limited Company (NASDAQ:KAL) dropped 32.5% to close at $0.2768.
• Tenet Healthcare Corporation (NYSE:THC) dipped 31% to close at $37.50 after the company reported worse-than-expected Q3 sales results and issued Q4 and FY22 adjusted EPS and sales guidance below estimates.
• Snap Inc. (NYSE:SNAP) fell 28.1% to close at $7.76 following Q3 results. The company said it will not provide Q4 expectations due to uncertainties in the operating environment but believes it is likely that year-over-year revenue growth will decelerate as it moves through Q4. The company also said total time spend watching content in the US decreased 5% year over year.
• authID Inc. (NASDAQ:AUID) dropped 27.5% to close at $1.00.
• Sientra, Inc. (NASDAQ:SIEN) fell 26.4% to close at $0.29. Sientra recently announced a proposed public offering.
• SVB Financial Group (NASDAQ:SIVB) dropped 24% to $230.03 after the company reported Q3 earnings results. Following earnings, multiple firms downgraded the stock.
• Starry Group Holdings, Inc. (NYSE:STRY) fell 22.7% to close at $0.8501. Starry announced a 50% workforce reduction and withdrew FY22 guidance.
• Kala Pharmaceuticals, Inc. (NASDAQ:KALA) fell 20% to close at $8.00. Kala Pharmaceuticals announced a 1-for-50 reverse stock split.
• SenesTech, Inc. (NASDAQ:SNES) shares fell 19.5% to close at $0.2253 after declining around 18% on Thursday.
• COMSovereign Holding Corp. (NASDAQ:COMS) fell 19.5% to close at $0.0808.
• Quanergy Systems, Inc. (NYSE:QNGY) fell 19.1% to close at $1.53.
• 9 Meters Biopharma, Inc. (NASDAQ:NMTR) declined 19% to close at $2.18.
• Eterna Therapeutics Inc. (NASDAQ:ERNA) dropped 18.5% to settle at $3.65.
• Alfi, Inc. (NASDAQ:ALF) fell 16.1% to close at $0.2432.
• Rubicon Technologies, Inc. (NYSE:RBT) fell 15.4% to close at $1.92.
• Katapult Holdings, Inc. (NASDAQ:KPLT) dropped 15.1% to close at $0.9335.
• Bit Origin Ltd (NASDAQ:BTOG) fell 14.9% to close at $0.2722.
• Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) fell 14.8% to close at $3.35.
• Community Health Systems, Inc. (NYSE:CYH) dipped 13.9% to close at $2.05.
• Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) dropped 12.8% to settle at $7.10. Aurinia Pharmaceuticals announced departure of Executive Vice President, Research and Chief Medical Officer.
• NLS Pharmaceutics AG (NASDAQ:NLSP) dipped 12.1% to settle at $0.4792.
• Ascent Solar Technologies, Inc. (NASDAQ:ASTI) dropped 10.6% to close at $4.58.
• Zovio Inc (NASDAQ:ZVO) declined 9.5% to close at $0.1766 after declining 7% on Thursday.
• First Financial Bankshares, Inc. (NASDAQ:FFIN) dipped 9.1% to close at $39.10. First Finl Bankshares posted Q3 EPS of $0.41.
• Robert Half International Inc. (NYSE:RHI) shares fell 8.6% to close at $73.01 after reporting downbeat Q3 earnings.
• Surgery Partners, Inc. (NYSE:SGRY) dropped 7.4% to close at $24.33.
• Pinterest, Inc. (NYSE:PINS) fell 6.4% to close at $21.50 in sympathy with Snap, which gave an uncertain fourth-quarter outlook.
• HCA Healthcare, Inc. (NYSE:HCA) fell 5.7% to close at $196.66 after the company reported worse-than-expected Q3 sales results.
• Twitter, Inc. (NYSE:TWTR) shares fell 4.9% to close at $49.89. The U.S. is reportedly discussing the possibility of subjecting Elon Musk’s companies to national security reviews. Musk has also been locked in a battle over buying Twitter. The U.S. government is reportedly unhappy with the billionaire mobilizing financing from foreign high-net-worth individuals to consummate the deal.

Posted In: ALF AMPX APCX ASTI ATRA AUID AUPH BHVN BNTX BTCY BTOG CADL CALT COMS CYH CYTO EFOI ENSV ERNA FFIN